SOURCE: BIOLASE Technology, Inc.

November 22, 2005 20:03 ET

BIOLASE to Present at Lazard Capital Markets Life Sciences Conference

SAN CLEMENTE, CA -- (MARKET WIRE) -- November 22, 2005 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that Robert E. Grant, President and CEO, and John W. Hohener, Executive Vice President and CFO, will present at the Lazard Capital Markets Life Sciences Conference in New York, NY on Wednesday, November 30, 2005 at 10:00 AM EST.

The presentation will be accessible by live web cast on the investor relations section of BIOLASE's web site at www.biolase.com. A replay of the web cast will be available on BIOLASE's web site for 60 days.

The Lazard Capital Markets Life Sciences Conference occurs November 29 - 30 at The New York Palace Hotel in New York, NY.

About BIOLASE

BIOLASE Technology, Inc. (http://www.biolase.com) is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. The Company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the Waterlase® system, is the best selling dental laser system. The Waterlase® system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The Company also offers the LaserSmile™ system, which uses a laser to perform soft tissue and cosmetic procedures, including tooth whitening.

For further information, please contact: Robert E. Grant, President & CEO; John W. Hohener, Executive Vice President and CFO; or Scott Jorgensen, Director of Finance & Investor Relations, of BIOLASE Technology, Inc., +1-949-361-1200.

Contact Information

  • Contacts:
    Robert E. Grant
    President & CEO
    BIOLASE Technology, Inc.

    John W. Hohener
    Executive Vice President and CFO
    BIOLASE Technology, Inc.

    Scott Jorgensen
    Director of Finance & Investor Relations
    BIOLASE Technology, Inc.

    +1-949-361-1200